To evaluate the clinical significance of CAV1 in HCC, we compared single-cell RNA-seq (scRNA-seq) data (n = 14) with bulk RNA-sequencing data obtained from a separate HCC cohort (n = 55) that included patient follow-up information (Fig. 7A). This evidence concerns the gene CAV1 and hepatocellular carcinoma.